NEW YORK, Aug. 7 – Illumina met Wall Street expectations on Tuesday as it posted a second-quarter net loss of $5.9 million, or $0.20 per share, compared with $5.3 million, or $0.25, for the same period last year.

Total revenue in the quarter ended June 30 was $470,000, surpassing the $79,000 that the functional genomics company posted for the second quarter 2000, an increase it attributed to a strong performance by its oligo service business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.